125 related articles for article (PubMed ID: 12054088)
1. Nuvion. Protein Design Labs.
Trajkovic V
Curr Opin Investig Drugs; 2002 Mar; 3(3):411-4. PubMed ID: 12054088
[TBL] [Abstract][Full Text] [Related]
2. ISA 247: trans-ISA 247, trans-R 1524, ISA(TX)247, ISAtx 247, ISATx247, LX 211, LX211, R 1524, R-1524.
Drugs R D; 2007; 8(2):103-12. PubMed ID: 17324008
[TBL] [Abstract][Full Text] [Related]
3. TRX-4 (TolerRx Inc).
Brown WM
IDrugs; 2006 Apr; 9(4):283-91. PubMed ID: 16596483
[TBL] [Abstract][Full Text] [Related]
4. IDEC-131. IDEC/Eisai.
Dumont FJ
Curr Opin Investig Drugs; 2002 May; 3(5):725-34. PubMed ID: 12090546
[TBL] [Abstract][Full Text] [Related]
5. Alicaforsen. Isis Pharmaceuticals.
Gewirtz AT; Sitaraman S
Curr Opin Investig Drugs; 2001 Oct; 2(10):1401-6. PubMed ID: 11890355
[TBL] [Abstract][Full Text] [Related]
6. Pexelizumab Alexion.
Whiss PA
Curr Opin Investig Drugs; 2002 Jun; 3(6):870-7. PubMed ID: 12137406
[TBL] [Abstract][Full Text] [Related]
7. YM-337. Yamanouchi.
Kamath S; Lip GY
Curr Opin Investig Drugs; 2001 Aug; 2(8):1093-6. PubMed ID: 11892919
[TBL] [Abstract][Full Text] [Related]
8. Fontolizumab Protein Design Labs.
Dumont FJ
Curr Opin Investig Drugs; 2005 May; 6(5):537-44. PubMed ID: 15912969
[TBL] [Abstract][Full Text] [Related]
9. Everolimus. Novartis.
Dumont FJ
Curr Opin Investig Drugs; 2001 Sep; 2(9):1220-34. PubMed ID: 11717808
[TBL] [Abstract][Full Text] [Related]
10. Alefacept (Biogen).
Bashir SJ; Maibach HI
Curr Opin Investig Drugs; 2001 May; 2(5):631-4. PubMed ID: 11569937
[TBL] [Abstract][Full Text] [Related]
11. Cladribine. Ortho Biotech Inc.
Tortorella C; Rovaris M; Filippi M
Curr Opin Investig Drugs; 2001 Dec; 2(12):1751-6. PubMed ID: 11892941
[TBL] [Abstract][Full Text] [Related]
12. IDEC-114 (IDEC).
Schopf RE
Curr Opin Investig Drugs; 2001 May; 2(5):635-8. PubMed ID: 11569938
[TBL] [Abstract][Full Text] [Related]
13. Oprelvekin. Genetics Institute.
Sitaraman SV; Gewirtz AT
Curr Opin Investig Drugs; 2001 Oct; 2(10):1395-400. PubMed ID: 11890354
[TBL] [Abstract][Full Text] [Related]
14. Eculizumab (Alexion).
Kaplan M
Curr Opin Investig Drugs; 2002 Jul; 3(7):1017-23. PubMed ID: 12186261
[TBL] [Abstract][Full Text] [Related]
15. MethyPatch Noven.
Sane N; McGough JJ
Curr Opin Investig Drugs; 2002 Aug; 3(8):1222-4. PubMed ID: 12211419
[TBL] [Abstract][Full Text] [Related]
16. Ezetimibe. Schering-Plough.
Meng CQ
Curr Opin Investig Drugs; 2002 Mar; 3(3):427-32. PubMed ID: 12054091
[TBL] [Abstract][Full Text] [Related]
17. ABT-874, a fully human monoclonal anti-IL-12/IL-23 antibody for the potential treatment of autoimmune diseases.
Ding C; Xu J; Li J
Curr Opin Investig Drugs; 2008 May; 9(5):515-22. PubMed ID: 18465662
[TBL] [Abstract][Full Text] [Related]
18. Abetimus (La Jolla pharmaceuticals).
Lorenz HM
Curr Opin Investig Drugs; 2002 Feb; 3(2):234-9. PubMed ID: 12020052
[TBL] [Abstract][Full Text] [Related]
19. DP-VPA D-Pharm.
Labiner DM
Curr Opin Investig Drugs; 2002 Jun; 3(6):921-3. PubMed ID: 12137414
[TBL] [Abstract][Full Text] [Related]
20. Drug evaluation: zanolimumab, a human monoclonal antibody targeted against CD4.
Assaf C; Sterry W
Curr Opin Mol Ther; 2007 Apr; 9(2):197-203. PubMed ID: 17458175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
